Public interest groups and funding organizations are demanding that clinical trials include diverse study populations-from the standpoint of age, gender, and ethnicity. What do you think is the reasoning behind this demand? Based on what you have read in this chapter as well as your own experiences, what are the advantages and disadvantages of using diverse study groups in clinical trials?